First generic Atorvastatin in Spain launched by Actavis’ clients
The product, Atorvastatin Magnesium, has been launched by four of Spain’s largest generic pharmaceutical companies. Actavis recently announced that it...
Actavis and ASKA finalize agreement for generic pharmaceutical company in Japan
Actavis Group and Japan’s ASKA Pharmaceutical have formally signed an agreement establishing a joint company: Actavis ASKA K.K. with its head office i...
Actavis in business alliance with a Japanese generic pharmaceutical manufacturer
Actavis announced a preliminary agreement with ASKA Pharmaceutical concerning the establishment of a joint company: Actavis ASKA Co., Ltd. The plan is...
Actavis breast cancer drug approved in the US
Actavis, a generic drugs manufacturer based in Iceland, has received approval from the US Food & Drug Administration to market the generic breast ...
Actavis reduces drug prices in Iceland
Actavis, the generic drug manufacturer, has announced it has reduced the price of 40 pharmaceuticals on the Icelandic market from 1st October. The mov...
Actavis represented at Frankfurt conference
Employees from many of Actavis Group‘s diverse departments worldwide will be present at this year’s annual CPhI conference, which is held ...